Trevor Resnick, MD, on Perampanel for Secondarily Generalized Seizures

Fumarate Bioequivalent for MS, Embrace Smartband Approval, Alzheimer Biomarkers, Perampanel DataПодробнее

Fycompa (Perampanel)Подробнее

Cannabidiol Use in Seizure DisordersПодробнее

Secondary Generalized SeizureПодробнее

Trevor Resnick, MD: Treating Epilepsy By Blending Technology, Genetics, and PharmacologicsПодробнее

Cannabidiol Tolerance in Patients with Seizure DisordersПодробнее

When to Initiate Therapy in Patients With EpilepsyПодробнее

PERAMPANEL- newer anti seizure medication- everything you need to knowПодробнее

Steve Chung, MD: Perampanel’s Effect on Insomnia in Patients With EpilepsyПодробнее

AES Highlights: Resnick on Study 307Подробнее

Jacqueline A. French, MD: Cenobamate’s Possible Future Impact In Seizure ControlПодробнее

Parting Advice on Managing Patients With EpilepsyПодробнее

James Wheless, MDJames Wheless, MD: Perampanel Shows Sustained Real-World EfficacyПодробнее

A Treatment Option for Uncontrolled Partial-Onset SeizuresПодробнее

Lancaster & Berks Epilepsy Education ExchangeПодробнее

Perampanel in therapy - Video abstract 63951Подробнее

What is Perampanel and What are the Side Effects?Подробнее

Fycompa® (perampanel) Mechanism of Action in EpilepsyПодробнее